Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Rite Aid Corporation is a pharmaceutical retailers business based in the US. Rite Aid Corporation shares (RAD) are listed on the NYSE and all prices are listed in US Dollars. Rite Aid Corporation employs 50,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $10.14 |
|---|---|
| 52-week range | $10.01 - $32.48 |
| 50-day moving average | $13.00 |
| 200-day moving average | $15.75 |
| Wall St. target price | $14.00 |
| PE ratio | 1551.16 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-3.11 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $10.14 from 2022-01-26
| 1 week (2022-01-19) | -12.74% |
|---|---|
| 1 month (2021-12-23) | -27.36% |
| 3 months (2021-10-27) | -21.76% |
| 6 months (2021-07-27) | -32.13% |
| 1 year (2021-01-27) | -63.98% |
|---|---|
| 2 years (2020-01-27) | -16.89% |
| 3 years (2019-01-25) | 964.79% |
| 5 years (2017-01-27) | 46.32% |
Valuing Rite Aid Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Rite Aid Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Rite Aid Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1551x. In other words, Rite Aid Corporation shares trade at around 1551x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Rite Aid Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.87. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Rite Aid Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Rite Aid Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $419.3 million.
The EBITDA is a measure of a Rite Aid Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $24.4 billion |
|---|---|
| Operating margin TTM | 0.49% |
| Gross profit TTM | $4.7 billion |
| Return on assets TTM | 0.79% |
| Return on equity TTM | -3102.1% |
| Profit margin | -0.69% |
| Book value | $8.71 |
| Market capitalisation | $627 million |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Rite Aid Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 32
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Rite Aid Corporation's overall score of 32 (as at 12/31/2018) is nothing to write home about – landing it in it in the 58th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Rite Aid Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 5/100
Rite Aid Corporation's environmental score of 5 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Rite Aid Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 5/100
Rite Aid Corporation's social score of 5 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Rite Aid Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 5/100
Rite Aid Corporation's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Rite Aid Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Rite Aid Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Rite Aid Corporation hasn't always managed to keep its nose clean.
Rite Aid Corporation was last rated for ESG on: 2019-01-01.
| Total ESG score | 32 |
|---|---|
| Total ESG percentile | 57.58 |
| Environmental score | 5 |
| Environmental score percentile | 5 |
| Social score | 5 |
| Social score percentile | 5 |
| Governance score | 5 |
| Governance score percentile | 5 |
| Level of controversy | 3 |
We're not expecting Rite Aid Corporation to pay a dividend over the next 12 months.
Rite Aid Corporation's shares were split on a 1:20 basis on 21 April 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Rite Aid Corporation shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Rite Aid Corporation shares which in turn could have impacted Rite Aid Corporation's share price.
Over the last 12 months, Rite Aid Corporation's shares have ranged in value from as little as $10.01 up to $32.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Rite Aid Corporation's is 0.9128. This would suggest that Rite Aid Corporation's shares are less volatile than average (for this exchange).
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, pet care, and other every day and convenience products, as well as brand and generic prescription drugs. It also operates retail clinics that provide treatment for common conditions; and provides preventative services. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments.
Read our expert analysis on Vigorus and how the token will perform in the future.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.